Skip to main content
Livermore
Livermore
ZHEN

Navidea Biopharmaceuticals, Inc.

NAVBDelisted Jan 16, 2024
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000810509

Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in Navidea Biopharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

NAVB is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023

Institutional holders
2
0 vs. Q1 2024
Shares held
360
0 (0.0%) vs. Q1 2024
Total value
$0
−$13 (−100.0%) vs. Q1 2024
New holders
0
0 more added
Sold out
0
0 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NAVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 2 institutions
Q1 2021: 35 institutionsQ2 2021: 31 institutionsQ3 2021: 29 institutionsQ4 2021: 31 institutionsQ1 2022: 25 institutionsQ2 2022: 26 institutionsQ3 2022: 25 institutionsQ4 2022: 28 institutionsQ1 2023: 30 institutionsQ2 2023: 23 institutionsQ3 2023: 24 institutionsQ4 2023: 4 institutionsQ1 2024: 2 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 1 institutionQ1 2025: 2 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $0
Q1 2021: $3.77MQ2 2021: $3.08MQ3 2021: $2.76MQ4 2021: $1.68MQ1 2022: $1.19MQ2 2022: $1.08MQ3 2022: $379.6KQ4 2022: $339.3KQ1 2023: $364.4KQ2 2023: $138.5KQ3 2023: $225.8KQ4 2023: $469Q1 2024: $13Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NAVB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20252$0
Q3 20251$0
Q2 20251$0
Q1 20252$0
Q4 20241$0
Q3 20242$0
Q2 20242$0
Q1 20242$13
Q4 20234$469
Q3 202324$225.8K
Q2 202323$138.5K
Q1 202330$364.4K
Q4 202228$339.3K
Q3 202225$379.6K
Q2 202226$1.08M
Q1 202225$1.19M
Q4 202131$1.68M
Q3 202129$2.76M
Q2 202131$3.08M
Q1 202135$3.77M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Navidea Biopharmaceuticals, Inc.; share changes are against Q1 2024.

Institutions holding NAVB in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Parallel Advisors, LLC350$00.00%00.0%Unchanged
WR Wealth Planners, LLC10$00.00%00.0%Unchanged